| Literature DB >> 35821468 |
Diego Benítez1, Andrea Medeiros2,3, Cristina Quiroga2, Marcelo A Comini4.
Abstract
This chapter describes a viability assay for the intracellular (amastigote) and clinically relevant form of Leishmania infantum that is based on the detection of bioluminescence (BL) signal. The assay uses a reporter cell line of L. infantum that expresses constitutively a redshifted luciferase from Photinus pyralis and murine macrophages (cell line J774.A1) as host cells for infection. The host cell line was selected because it is a differentiated cell line, easy to manipulate in vitro, and advantageous for ethical reasons. This chapter introduces an assay designed for the screening of bioactive compounds/molecules employing a 96-well microplate and a 24 h treatment. The assay setup shows excellent balance between simplicity (cell culture manipulation/infection and timing) and quality parameters, as well as potential to detect drug-like molecules acting in a fast and cytotoxic manner.Entities:
Keywords: Drug discovery; Leishmania infantum; Redshifted luciferase; Viability assay; Visceral leishmaniasis
Mesh:
Substances:
Year: 2022 PMID: 35821468 DOI: 10.1007/978-1-0716-2453-1_10
Source DB: PubMed Journal: Methods Mol Biol ISSN: 1064-3745